Phantom462
Rising Star
Hello,
New to the DMT world, and not having partaken I though I'd do an insane amount of research into the current renaissance in the phycological world in relation to psychedelics. Please feel free to give me some feedback on this paper:
(Psychedelics Promote Structural and Functional Neural Plasticity - PMC) Neuroscientific research indicates that DMT and other psychedelics act as “psychoplastogens” – compounds that promote neuronal growth and connectivity. The illustration above depicts how psychedelics like LSD, DOI, and DMT increase dendritic branching and synaptic density in cortical neurons, leading to enhanced neural plasticity (Psychedelics Promote Structural and Functional Neural Plasticity - PMC). Such structural changes (increased neurites and spines) provide a biological foundation for the cognitive and emotional flexibility reported after psychedelic therapy.
On a functional level, this neuroplastic surge may create an “open window” for change. During and shortly after a DMT experience, the brain exhibits altered activity patterns (for instance, reduced activity in rigid networks like the default mode network and altered limbic responses) that correlate with psychological openness and flexibility. One fMRI study of ayahuasca (an orally active DMT brew) found that during the acute experience, the amygdala’s reactivity to negative emotional stimuli was dampened, while higher-order regions (insular and prefrontal cortex) showed increased engagement (Emotion regulation effects of Ayahuasca in experienced subjects during implicit aversive stimulation: An fMRI study - PubMed). In essence, the brain enters a more malleable, less fear-driven state. The researchers concluded that ayahuasca “can promote an emotion regulation mechanism in response to aversive stimuli”, with corresponding reductions in anxiety and inner resistance (Emotion regulation effects of Ayahuasca in experienced subjects during implicit aversive stimulation: An fMRI study - PubMed). This aligns with therapeutic goals: by quieting overactive fear or habit circuits and boosting new neural pathways, DMT may allow entrenched thoughts and behaviors to be “rewired” with new, healthier patterns.
Key methods used to reinforce neuroplastic changes after a DMT session include:
Differences arise in duration and intensity of the subjective experience, which can influence how therapeutic integration is approached. DMT (in smoked or intravenous form) produces an extremely rapid and intense psychedelic state that lasts only ~15–30 minutes (hence it’s sometimes called a “blast-off” into an immersive hallucination). This brevity means that during the session there is limited opportunity for interactive psychotherapy – the person is often “far away” in their mind – so most therapeutic work with DMT happens in preparation and after the session. In contrast, psilocybin or LSD sessions last 4–8+ hours, during which a therapist can potentially guide the patient through various emotions or use techniques in real-time. Neither approach is inherently “better,” but they are different. Some experimental models are exploring extended DMT infusions to lengthen the experience for therapeutic purposes, but these are in early stages. Ayahuasca, the traditional DMT-containing brew, lasts longer (2–4 hours) due to the MAOIs co-administered, and in ceremonial or therapeutic contexts, facilitators often interact with participants (through music, counseling, etc.) during the experience, somewhat akin to how psilocybin sessions are conducted.
When it comes to therapeutic outcomes, much of the published research to date has focused on psilocybin and MDMA (for PTSD) in clinical trials, simply because these entered the research arena earlier. Those studies have shown remarkable efficacy for depression, end-of-life anxiety, PTSD, and addiction. DMT and ayahuasca studies, while fewer, show comparable promising outcomes. For example, small clinical trials of ayahuasca in treatment-resistant depression found rapid antidepressant effects within 1–2 days after a single session, superior to placebo, with improvements still significant a week later ([EPUB] The Impact of Ayahuasca on Suicidality: Results From a ... - Frontiers). Observational studies in naturalistic settings have reported reduced symptoms of depression and anxiety after ayahuasca ceremonies, and increased mindfulness and psychological well-being. In one report, ayahuasca users experienced sub-acute improvements in emotion regulation (e.g. less avoidance of emotions, more acceptance) and these improvements correlated with better cognitive performance and mood (Emotion regulation effects of Ayahuasca in experienced subjects ...) (Persisting Effects of Ayahuasca on Empathy, Creative Thinking ...). Another study noted that ayahuasca can help people engage cognitive reappraisal of negative experiences – essentially reframing thoughts – even acutely (Prospective examination of the therapeutic role of psychological ...). These are the same kinds of benefits attributed to psilocybin therapy. Similarly, 5-MeO-DMT (a short-acting psychedelic distinct from N,N-DMT) has shown in survey studies to produce longer-term increases in life satisfaction and mindfulness and decreases in stress up to 4 weeks after use (The potential of 5‐methoxy‐N,N‐dimethyltryptamine in the treatment ...) (though more controlled research is needed). The consensus in the field is that the classical psychedelics do not wildly differ in what psychological benefits they can produce – factors like set (mindset), setting, guidance, and the individual’s personal readiness likely play a bigger role in outcomes than the specific compound used. All these substances can, under the right conditions, facilitate mystical-type experiences, deep emotional breakthroughs, and cognitive flexibility that translate to therapeutic gains (Learning to Let Go: A Cognitive-Behavioral Model of How Psychedelic Therapy Promotes Acceptance - PMC). Indeed, a broad review of psychedelic therapy cases found that psilocybin, LSD, and ayahuasca all can lead to “sustained symptom reductions” in various disorders when paired with therapy (Learning to Let Go: A Cognitive-Behavioral Model of How Psychedelic Therapy Promotes Acceptance - PMC).
However, some practical distinctions are worth noting: DMT’s intensity can be challenging for some individuals – the onset is so fast that it can be jarring, and the content can be extremely bizarre or ego-dissolving. This can be overwhelming, though the short duration means even a difficult trip is over soon. Psilocybin’s gentler onset and longer plateau might allow a more gradual confrontation of issues. From a cognitive enhancement perspective, the short duration of DMT could be seen as a benefit (a powerful session could be done in an hour, vs. a whole day for an LSD session), but it also means there is less time during the experience to consciously work on a problem or engage in a task. Thus, for goals like improving creativity or problem-solving, some researchers have looked more at LSD or psilocybin in moderate doses where participants can still communicate and work on puzzles. DMT’s contribution here might be more about giving a lightning bolt of insight which is then unpacked afterward. On the other hand, ayahuasca’s rich tradition of integration in community (sharing circles, ritual practice) is a strength that often accompanies DMT use in that form, potentially yielding very strong support systems for change – something individual psilocybin sessions might lack unless done in group therapy settings.
In terms of safety and side-effect profile, DMT and other classical psychedelics are all non-addictive and physiologically well-tolerated (they do not cause organ damage and have low toxicity) (Psychedelics and Neuroplasticity: A Systematic Review Unraveling the Biological Underpinnings of Psychedelics - PMC). The risks are mainly psychological (e.g. precipitating anxiety or, rarely, psychosis in vulnerable individuals) and these apply to all in the class. No clear evidence suggests, for instance, that DMT is more likely to cause adverse reactions than psilocybin; if anything, the extensive ceremonial use of ayahuasca over centuries provides a case for its relative safety when used responsibly.
Overall, if one’s goal is cognitive enhancement, motivation, and emotional resilience, the choice of psychedelic may be less important than the surrounding framework. DMT is a valid option that can produce profound insights and neuroplastic changes, but similar benefits might be achieved with psilocybin or LSD given proper guidance. The difference may lie in personal preference (some may prefer the brevity of DMT or the spiritual context of ayahuasca, whereas others might favor the depth of a longer psilocybin journey) and logistical considerations. Importantly, the scientific evidence base is strongest for psilocybin (due to more trials), but encouraging studies and anecdotal reports suggest that DMT/ayahuasca is equally effective in catalyzing positive change when delivered in a supportive therapeutic model. In practice, therapists and researchers are increasingly interested in combining these substances with modern therapeutic techniques – whether it’s DMT with CBT-based integration, or LSD with psychodynamic therapy – to see if certain pairings yield optimal results. As of now, no head-to-head trials definitively prove one psychedelic as superior to another for cognitive or emotional outcomes; ongoing studies are more focused on whether psychedelic-assisted therapy as a whole works, and it consistently does show beneficial effects across different substances.
For clinicians and researchers, the findings underscore the importance of developing structured integration protocols and possibly combining DMT sessions with established therapies (CBT, ACT, etc.) to maximize outcomes. The notion of psychedelics reopening a “critical period” of neuroplasticity (Critical Period Plasticity as a Framework for Psychedelic-Assisted ...) suggests that we have a limited but significant timeframe to introduce therapeutic learning when it will stick best. By treating the days after DMT as a form of accelerated learning bootcamp – focusing the patient on new thought patterns, exposing them to positive experiences, and encouraging adaptive behaviors – we can harness the neuroplastic boost for durable benefit. This represents a shift from seeing medication and therapy as separate: in psychedelic therapy, the medicine makes the brain receptive, and therapy provides the new input to be encoded.
It’s also worth noting the experimental nature of this field. While early results are exciting, more research is needed to fully understand optimal protocols (e.g. the ideal number of DMT sessions, how to personalize integration strategies, managing any risks). Comparisons between different psychedelics will help determine if one might be better suited for certain goals – for instance, perhaps DMT (ayahuasca) could be especially useful in spiritual or creative growth contexts, whereas psilocybin might be slightly more grounded for step-by-step cognitive training, but this remains to be empirically tested.
In practical application, those using DMT in ceremonial or non-clinical settings can still apply these principles: have integration activities lined up. For example, if you attend an ayahuasca retreat, plan for what you will do in the weeks afterward – therapy, journaling, making lifestyle changes – to nurture the seeds planted in the ceremony. Communities of experienced users often stress that “the real work begins after the ceremony.” The scientific concept of neuroplasticity gives credence to that, explaining why continued work is needed to remodel the brain in lasting ways.
In summary, DMT can be a powerful tool for cognitive and emotional growth when used responsibly and followed by intentional integration practices. It effectively “loosens the clay” of the mind, but it’s the subsequent shaping and molding – through conscious effort and support – that determines the ultimate outcomes. With a structured approach that reinforces neuroplastic changes post-session, individuals can reasonably expect improvements in their thinking (more creativity, mental flexibility), their drive (renewed motivation and sense of purpose), and their emotional well-being (better regulation, resilience). As research progresses, we anticipate more refined therapeutic models and evidence-based techniques to optimize these outcomes. For now, the convergence of traditional wisdom (from indigenous use of DMT in ayahuasca) and modern neuroscience is teaching us how to integrate the profound experiences DMT offers into enduring positive change, marking an exciting frontier in mental health and human cognitive enhancement ((PDF) Psychedelics and the new behaviourism: considering the integration of third-wave behaviour therapies with psychedelic-assisted therapy) ((PDF) Psychedelics and the new behaviourism: considering the integration of third-wave behaviour therapies with psychedelic-assisted therapy).
Sources:
New to the DMT world, and not having partaken I though I'd do an insane amount of research into the current renaissance in the phycological world in relation to psychedelics. Please feel free to give me some feedback on this paper:
DMT, Neuroplasticity, and Experimental Therapeutic Approaches
DMT’s Impact on Neuroplasticity and the Brain
N,N-Dimethyltryptamine (DMT) is a powerful psychedelic known for inducing intense, short-lived hallucinogenic experiences. Beyond its subjective effects, emerging research shows that DMT can profoundly influence neuroplasticity – the brain’s ability to form new connections and adapt. At the cellular level, DMT (like other classic psychedelics) promotes the growth of neuronal dendrites and the formation of new synapses, similar to how fast-acting antidepressants like ketamine work (Psychedelics Promote Structural and Functional Neural Plasticity - PMC). For example, preclinical studies have demonstrated that psychedelics such as DMT, LSD, and psilocin “increase dendritic arbor complexity, promote dendritic spine growth, and stimulate synapse formation”, indicating a direct biological boost to neural connectivity (Psychedelics Promote Structural and Functional Neural Plasticity - PMC). These changes are mediated largely via serotonin 5-HT2A receptor signaling, triggering increased expression of neurotrophic factors like BDNF (Brain-Derived Neurotrophic Factor) which support neural growth (Psychedelics and Neuroplasticity: A Systematic Review Unraveling the Biological Underpinnings of Psychedelics - PMC) (Psychedelics and Neuroplasticity: A Systematic Review Unraveling the Biological Underpinnings of Psychedelics - PMC). Notably, a single psychedelic dose can induce rapid plasticity-related gene expression and dendritic growth that outlasts the acute drug effects, while repeated administrations have been shown to elevate markers of neurogenesis for weeks (Psychedelics and Neuroplasticity: A Systematic Review Unraveling the Biological Underpinnings of Psychedelics - PMC). In short, DMT acts as a potent “psychoplastogen”, priming the brain for reorganization and learning.(Psychedelics Promote Structural and Functional Neural Plasticity - PMC) Neuroscientific research indicates that DMT and other psychedelics act as “psychoplastogens” – compounds that promote neuronal growth and connectivity. The illustration above depicts how psychedelics like LSD, DOI, and DMT increase dendritic branching and synaptic density in cortical neurons, leading to enhanced neural plasticity (Psychedelics Promote Structural and Functional Neural Plasticity - PMC). Such structural changes (increased neurites and spines) provide a biological foundation for the cognitive and emotional flexibility reported after psychedelic therapy.
On a functional level, this neuroplastic surge may create an “open window” for change. During and shortly after a DMT experience, the brain exhibits altered activity patterns (for instance, reduced activity in rigid networks like the default mode network and altered limbic responses) that correlate with psychological openness and flexibility. One fMRI study of ayahuasca (an orally active DMT brew) found that during the acute experience, the amygdala’s reactivity to negative emotional stimuli was dampened, while higher-order regions (insular and prefrontal cortex) showed increased engagement (Emotion regulation effects of Ayahuasca in experienced subjects during implicit aversive stimulation: An fMRI study - PubMed). In essence, the brain enters a more malleable, less fear-driven state. The researchers concluded that ayahuasca “can promote an emotion regulation mechanism in response to aversive stimuli”, with corresponding reductions in anxiety and inner resistance (Emotion regulation effects of Ayahuasca in experienced subjects during implicit aversive stimulation: An fMRI study - PubMed). This aligns with therapeutic goals: by quieting overactive fear or habit circuits and boosting new neural pathways, DMT may allow entrenched thoughts and behaviors to be “rewired” with new, healthier patterns.
Post-Session Integration and Reinforcement Techniques
Capitalizing on DMT-induced neuroplasticity requires more than the drug alone – what happens after the psychedelic session is crucial. Integration therapy refers to the process of helping individuals make sense of the insights and emotions from the DMT experience and solidify positive changes. In practice, integration typically occurs in the days or weeks following a session (once the acute effects have subsided) and can take many forms: psychotherapy sessions, journaling, meditation, or group support meetings. The aim is to reinforce and apply the revelations or new perspectives gained under DMT, effectively bridging the psychedelic state with real-life change (Frontiers | Critical Period Plasticity as a Framework for Psychedelic-Assisted Psychotherapy). As one overview describes, the psychedelic treatment paradigm involves a preparation phase, the dosing session itself, and then “insights are examined in integration sessions in the absence of the medicine” (Frontiers | Critical Period Plasticity as a Framework for Psychedelic-Assisted Psychotherapy). This deliberate post-session work helps translate fleeting psychedelic insights into lasting cognitive or behavioral modifications.Key methods used to reinforce neuroplastic changes after a DMT session include:
- Therapeutic Integration Sessions: One-on-one or group therapy discussions guided by a trained professional can help the individual process the DMT journey. The therapist may encourage the person to recount significant visions or realizations and explore their personal meaning. Through techniques borrowed from cognitive-behavioral therapy (CBT) or other modalities, the therapist helps connect insights to actionable goals or reframed beliefs in everyday life (Learning to Let Go: A Cognitive-Behavioral Model of How Psychedelic Therapy Promotes Acceptance - PMC). For example, if the DMT experience revealed new personal values or a different self-perspective, the integration session might involve exercises in values clarification, goal-setting, or challenging old thought patterns to align with those new insights (Learning to Let Go: A Cognitive-Behavioral Model of How Psychedelic Therapy Promotes Acceptance - PMC). This approach leverages the “belief relaxation” that occurs under psychedelics – after DMT, people may be less rigid in their self-beliefs – and uses therapy to reinforce more adaptive beliefs and behaviors while the mind is still flexible (Learning to Let Go: A Cognitive-Behavioral Model of How Psychedelic Therapy Promotes Acceptance - PMC) (Learning to Let Go: A Cognitive-Behavioral Model of How Psychedelic Therapy Promotes Acceptance - PMC).
- Cognitive-Behavioral Reinforcement: Some experimental protocols incorporate structured CBT techniques or “homework” in the post-DMT period to cement changes. This might involve practicing new coping skills or thought patterns that were introduced during the psychedelic session. One proposal suggests that specific CBT interventions (e.g. cognitive restructuring, exposure exercises, or acceptance training) can be strategically timed around psychedelic sessions to “amplify the acceptance-promoting effects” of the experience (Learning to Let Go: A Cognitive-Behavioral Model of How Psychedelic Therapy Promotes Acceptance - PMC). For instance, because DMT can facilitate confronting painful emotions or memories with less avoidance, therapists may assign exposure exercises or dialogues about those issues soon after the session, when the patient’s avoidance has been reduced and the brain’s capacity to form new associations is high (Learning to Let Go: A Cognitive-Behavioral Model of How Psychedelic Therapy Promotes Acceptance - PMC) (Learning to Let Go: A Cognitive-Behavioral Model of How Psychedelic Therapy Promotes Acceptance - PMC). By pairing the neuroplastic window with active skill training, the patient essentially re-learns emotional responses or thinking habits in a more positive way. Early clinical models note substantial overlaps between effective psychedelic therapy and techniques like acceptance and mindfulness from CBT traditions (Learning to Let Go: A Cognitive-Behavioral Model of How Psychedelic Therapy Promotes Acceptance - PMC) ((PDF) Psychedelics and the new behaviourism: considering the integration of third-wave behaviour therapies with psychedelic-assisted therapy), so combining them is a natural extension.
- Guided Practices (Mindfulness, Meditation, Journaling): Introducing or continuing mindfulness-based practices is another powerful way to harness post-DMT neuroplasticity. Meditation, breathwork, or yoga can help individuals remain grounded and aware of their thoughts and feelings, which aids in integrating the psychedelic experience. In fact, research suggests that participants who engage in regular meditation or spiritual practice alongside psychedelic use show more pronounced and lasting benefits. In a study on psilocybin (a similar 5-HT2A psychedelic), those who had meditation support before and after sessions reported greater improvements in domains like interpersonal closeness, life meaning, and coping ability ((PDF) Psychedelics and the new behaviourism: considering the integration of third-wave behaviour therapies with psychedelic-assisted therapy) ((PDF) Psychedelics and the new behaviourism: considering the integration of third-wave behaviour therapies with psychedelic-assisted therapy). Consistent with this, experts recommend developing mindfulness skills in the preparatory phase and “maintaining them subsequent to sessions to enhance integration of the psychedelic experience”, which appears to “potentiate some of the effects” of the therapy ((PDF) Psychedelics and the new behaviourism: considering the integration of third-wave behaviour therapies with psychedelic-assisted therapy). Journaling is also commonly encouraged: writing down the details of the DMT journey and the lessons learned shortly after the session can reinforce memory retention and provide material for reflection. These written or artistic integrations (such as drawing symbols or scenes from the experience) help transfer ephemeral insights into a concrete form that can be revisited later, counteracting the natural fading of psychedelic memories. Other guided practices might include breathwork, nature walks, or creative expression – activities that keep the mind engaged with the themes of the experience in a constructive way. All of these methods serve to continually re-stimulate the new neural pathways that DMT opened up, essentially training the brain to retain and strengthen those connections rather than letting them regress to old patterns.
- Behavioral Activation and Lifestyle Changes: Another aspect of integration is encouraging positive lifestyle changes while motivation is high. Many people emerge from a DMT or ayahuasca session with a sense of clarity about changes they want to make – quitting harmful habits, improving relationships, pursuing a meaningful project, etc. Therapists often help translate these intentions into actionable plans. Because neuroplasticity is elevated, actively practicing new behaviors or routines in the days and weeks after the session can more easily encode those habits. For example, someone who realizes the importance of social connection might be encouraged to immediately schedule regular interactions with loved ones; someone who discovers a passion for art might begin a daily creative practice. By taking advantage of the “afterglow” period of elevated mood and openness, patients can jump-start lifestyle adjustments (exercise, diet, meditation, creative work) that support long-term well-being. Early research in addiction treatment shows this to be promising – psychedelics can increase psychological flexibility and openness, which, when paired with guidance, result in positive behavior changes like cessation of smoking or reduction in substance use (Learning to Let Go: A Cognitive-Behavioral Model of How Psychedelic Therapy Promotes Acceptance - PMC). In sum, integration is about turning the malleability induced by DMT into tangible changes through consistent practice and supportive guidance.
Timeframes of Neuroplastic Changes and Expected Outcomes
How long do DMT-induced changes last? Research indicates there are distinct short-term, intermediate, and long-term effects – each with different characteristics and requiring different support. It’s important to set realistic expectations for what cognitive, emotional, or behavioral shifts can occur in each timeframe:- Short-Term (Immediate to Days Post-Session): In the immediate aftermath of a DMT experience (hours to a few days), individuals often report an “afterglow” period characterized by elevated mood, mental clarity, and openness. Acutely, there may be profound insights or perspective shifts during the session itself, but these can be fleeting unless captured. Within the first day or two, many people feel increased optimism, empathy, and a sense of wonder. For example, one study of ayahuasca ceremony participants found that the very next day after the session, measures of cognitive empathy, life satisfaction, and the ability to take an objective, non-judgmental view of oneself (decentering) were significantly higher than baseline (Frontiers | Persisting Effects of Ayahuasca on Empathy, Creative Thinking, Decentering, Personality, and Well-Being). Anxiety and negative affect often decrease in this window as well, as seen in reports of reduced neuroticism the morning after a psychedelic experience (Frontiers | Persisting Effects of Ayahuasca on Empathy, Creative Thinking, Decentering, Personality, and Well-Being). Biologically, the brain is flush with neurotrophic factors and synaptic proteins during this period, meaning it’s primed to encode new learning. However, without reinforcement, some of these benefits may be transient. It’s reasonable to expect in the short term: an improved mood and outlook, enhanced cognitive flexibility (willingness to consider new ideas or solutions), and a temporarily increased capacity for abstract or novel thinking. People often describe seeing creative connections or solutions more readily right after a psychedelic session. Emotional responsiveness is also heightened – both positive feelings of connection and, sometimes, vulnerability as raw material surfaces. Thus, support during this short-term phase (through debriefing, writing down insights, and a nurturing environment) is key to capitalize on the afterglow. By the end of a week or so, some of the immediate neurochemical aftereffects normalize, but if integration work is ongoing, psychological improvements can persist into the next phase.
- Medium-Term (Weeks to a Few Months): In the medium term, the initial glow tapers, but deeper changes begin to consolidate. With proper integration, many individuals maintain reductions in symptoms or improved cognitive-emotional patterns for several weeks or more. Clinical studies have shown that a single psychedelic therapy session can yield benefits at least one month out. For instance, in a trial of psilocybin for depression (a paradigm likely translatable to DMT therapy), patients showed increased cognitive flexibility up to 4 weeks post-treatment (Psilocybin therapy increases cognitive and neural flexibility in patients with major depressive disorder - PubMed). They made fewer perseverative errors on problem-solving tasks, indicating a sustained ability to “think outside the box” and break out of rigid thought loops. Notably, these cognitive gains persisted even as the acute drug effects had long worn off (Psilocybin therapy increases cognitive and neural flexibility in patients with major depressive disorder - PubMed). Psychologically, one month after a well-integrated psychedelic experience, people often exhibit lasting decreases in depression and anxiety scores, improved stress coping, and sometimes changes in personality measures (for example, sustained increases in openness to experience or reductions in trait avoidance). A week after ayahuasca, researchers observed that participants still had elevated levels of empathy, life satisfaction, and decentering compared to baseline (Frontiers | Persisting Effects of Ayahuasca on Empathy, Creative Thinking, Decentering, Personality, and Well-Being) (Frontiers | Persisting Effects of Ayahuasca on Empathy, Creative Thinking, Decentering, Personality, and Well-Being) – indicating that emotional and cognitive benefits can endure for at least days or weeks. In therapeutic contexts, significant improvements in motivation and outlook are often reported in the medium term: patients might find they have a renewed drive to engage in work or personal projects, or an ability to break from addictive behaviors, as the insights from DMT continue to influence daily decision-making. However, it’s also in this period (several weeks post-session) that without continued practice or occasional booster sessions, some gains may begin to fade. The brain’s heightened plasticity gradually returns toward baseline, so ongoing reinforcement (therapy sessions, habit change, mindfulness practice) through these weeks is recommended to lock in the positive changes. Many therapeutic protocols schedule follow-up sessions or at least check-ins during this phase to support the client as they implement changes sparked by the session.
- Long-Term (Months to Years): Long-term outcomes depend greatly on the individual’s continued integration efforts and whether they have additional psychedelic sessions. In some cases, a single transformative DMT session, well-integrated, can lead to enduring changes that last years – such as sustained remission from depression or a fundamentally altered outlook on life. More commonly, some effects will attenuate over time, but certain shifts in perspective can become essentially permanent. Scientific evidence from long-term ayahuasca (DMT brew) users provides insight into what prolonged, repeated exposure combined with integration can achieve. Cross-sectional studies of people who attend ayahuasca ceremonies regularly (e.g. multiple times a year for many years) show no signs of cognitive decline or psychological harm; in fact, these individuals tend to demonstrate enhanced cognitive function and well-being relative to non-users (Personality, psychopathology, life attitudes and neuropsychological performance among ritual users of Ayahuasca: a longitudinal study - PubMed) (Personality, psychopathology, life attitudes and neuropsychological performance among ritual users of Ayahuasca: a longitudinal study - PubMed). One longitudinal study found that over the course of one year, regular ayahuasca users maintained better performance on executive function tests (Stroop, card sorting, working memory tasks) and lower psychopathology than controls, alongside higher ratings of life purpose and psychosocial well-being (Personality, psychopathology, life attitudes and neuropsychological performance among ritual users of Ayahuasca: a longitudinal study - PubMed). This suggests that when neuroplastic experiences are reinforced by community and continual practice, the brain undergoes enduring positive reorganization. Neuroimaging studies add to this picture: long-term DMT/ayahuasca use has been associated with structural brain changes, such as increased cortical thickness in the anterior cingulate cortex (ACC) (A systematic review of human studies assessing psychiatric ...). The ACC is a region involved in emotion regulation and attention, so its growth might reflect the long-lasting strengthening of neural circuits for self-control and emotional processing. (Notably, these brain changes were not seen in non-users, highlighting a DMT-specific effect (A systematic review of human studies assessing psychiatric ...).) In terms of behavioral and emotional resilience, long-term outcomes can include a markedly reduced rate of relapse in addictions, sustained reductions in trauma symptoms, and an increase in traits like mindfulness, openness, and acceptance. However, it’s important to recognize that such enduring outcomes usually require continued effort – whether through periodic psychedelic sessions or ongoing personal work – to reinforce the initial gains. Many patients integrate psychedelic therapy as one component of a broader long-term mental health plan, which might involve periodic “booster” sessions (perhaps with longer-acting psychedelics or ayahuasca retreats) and consistent therapeutic or spiritual practices in between. In summary, the reasonable expectation is that DMT can catalyze significant change relatively quickly (within days), these changes can be sustained and even grow over several weeks with support, and under conducive conditions they may endure long-term – but long-lasting change typically correlates with sustained integration efforts or repeated therapeutic exposures.
Enhancing Cognitive Processing and Emotional Resilience
One of the exciting prospects of DMT therapy is the potential to not only relieve negative conditions (like depression or PTSD) but also enhance positive cognitive functions – such as creativity, abstract thinking, and learning capacity – and build emotional resilience. While research is still nascent, there are strategies and some evidence pointing to how DMT and its after-effects might be harnessed for these goals:- Optimizing Learning and Memory: The surge in neuroplasticity after DMT means the brain is in a heightened learning state. To optimize retention of new information or insights, timing your learning activities to coincide with this state can be beneficial. Practically, this could mean that in the days following a DMT session, one deliberately engages in studying or practicing skills that they want to improve. Psychotherapists often encourage patients to practice newly learned coping skills or review therapeutic insights repeatedly in the weeks post-session, as this is when the brain will most readily solidify those memories. Even outside of therapy, someone interested in cognitive enhancement might use the post-DMT window to tackle creative or intellectual work (once fully sober) with a fresh perspective. Anecdotal reports and historical observations suggest that psychedelics can facilitate creative problem-solving and perspective shifts that aid abstract thought processing. In the 1960s, for example, some engineers and scientists in experimental sessions were able to solve complex problems or design innovative solutions under the influence of psychedelics – an effect attributed to the compounds’ ability to break mental impasses and introduce novel associations. Modern research on lower doses echoes this: one study found that a microdose of psilocybin (a close analog of DMT) enhanced creativity (divergent thinking) without impairing analytical reasoning on tasks like Raven’s matrices (Frontiers | Psychedelic Cognition—The Unreached Frontier of Psychedelic Science). This suggests that psychedelics can open the mind to new ideas while retaining the capacity for logic, at least at mild doses. In a DMT context, because a full DMT trip is too immersive for concurrent tasks, the focus is on the afterglow period: users often report a clearer, more integrative thinking style after the experience, which could be applied to complex abstract problems (for example, a mathematician might perceive a theorem from a novel angle, or an artist might conceptualize a piece more holistically). To make these fleeting cognitive enhancements stick, experts recommend engaging actively with the material – for instance, writing down any novel ideas or solutions that emerged during the session, and then systematically working through them afterward. By doing so, one takes advantage of the brain’s plastic state to encode new patterns of thought. Supplementary techniques like spaced repetition (for factual information) or concept mapping (for abstract ideas) in the post-session week can further help transfer short-term insights into long-term knowledge. Essentially, treat the post-DMT brain like a sponge – it can absorb new information rapidly, but it’s up to the individual to provide that enriching content and repetition.
- Abstract Thought and Mathematical Reasoning: The question of whether DMT can improve something as concrete as mathematical reasoning is intriguing. There is no direct scientific study yet demonstrating improved math performance from DMT, but we can extrapolate from related findings on cognitive flexibility. Psychedelics tend to increase fluid thinking and broaden associative networks, which could help in fields like mathematics or engineering by allowing a person to see patterns or solutions that were previously obscured by mental ruts. For example, increased neural flexibility in the prefrontal cortex after psychedelics (Psilocybin therapy increases cognitive and neural flexibility in patients with major depressive disorder - PubMed) might translate to trying different approaches to a problem rather than getting stuck in one method. Some users report that during a psychedelic experience, they gain an intuitive “big picture” understanding of complex systems or abstract concepts. To harness this for a discipline like mathematics, any insights should be immediately written down or verbalized (since specific details can slip away post-trip). Then, during integration, one could work through the math problem step by step while recalling the new perspective experienced under DMT. Furthermore, engaging in logic puzzles or analytical discussions in the days post-session might take advantage of the lingering cognitive openness. It’s worth noting that high doses during the acute phase often temporarily impair focused analytical thinking – for instance, studies have shown that on acute psilocybin, people made more errors on executive-function tasks (like the Stroop test) (Frontiers | Psychedelic Cognition—The Unreached Frontier of Psychedelic Science), which is expected when perception is heavily altered. So the goal is not to perform calculations while tripping, but to let the experience broaden one’s conceptual framework and then apply it afterward. On the flip side, microdoses or very low doses of psychedelics might allow slight enhancement of focus or pattern recognition without hallucinations; however, controlled studies on microdosing show mixed results on cognitive measures (some find no significant improvement in abstract reasoning ability from microdoses alone (Frontiers | Psychedelic Cognition—The Unreached Frontier of Psychedelic Science)). Overall, any boost in abstract thought likely comes from qualitative changes in perspective and motivation rather than a quantifiable increase in IQ or computation speed. The practical takeaway is that DMT could inspire new ways to approach an abstract problem, and combining that inspiration with diligent practice and study in the integration period is the strategy to convert insight into concrete skill.
- Emotional Processing and Resilience: DMT’s intense psychoactive journey often brings individuals face-to-face with deep emotions – from euphoria and awe to fear and grief. This confrontation, when handled in a supportive setting, can effectively train emotional resilience. As described earlier, psychedelics can reduce activity in the brain’s fear centers (like the amygdala) while increasing engagement of regulatory regions, enabling a person to process trauma or negative emotions with less overwhelm (Emotion regulation effects of Ayahuasca in experienced subjects during implicit aversive stimulation: An fMRI study - PubMed) (Emotion regulation effects of Ayahuasca in experienced subjects during implicit aversive stimulation: An fMRI study - PubMed). Experientially, people often find that during a challenging DMT vision, if they learn to surrender and observe rather than panic, they emerge with a newfound confidence in facing difficulties. This is analogous to an accelerated emotional exposure therapy. Integration therapists often highlight these experiences to the client, noting how they were able to survive and even find meaning in a difficult emotional state during the trip – a lesson that can be applied to real-life stress. Indeed, clinical observations show improved emotion regulation after psychedelic therapy: one cross-sectional study found that psychedelic use was associated with increased emotion-regulation capacity in users, which in turn related to better relationship outcomes (less conflict with partners) ((PDF) Psychedelics and the new behaviourism: considering the integration of third-wave behaviour therapies with psychedelic-assisted therapy). Likewise, aspects of therapies like DBT (Dialectical Behavior Therapy), which teach distress tolerance, overlap with the psychedelic process – the idea of accepting and moving through distressing feelings is inherent to a challenging psychedelic journey ((PDF) Psychedelics and the new behaviourism: considering the integration of third-wave behaviour therapies with psychedelic-assisted therapy) ((PDF) Psychedelics and the new behaviourism: considering the integration of third-wave behaviour therapies with psychedelic-assisted therapy). To actively cultivate emotional resilience post-DMT, patients are encouraged to continue practices like mindfulness meditation, which reinforce a non-reactive awareness of feelings. They may also engage in therapy techniques that deliberately recall the challenging content from the session but now work with it in a conscious, controlled way (for example, discussing a traumatic memory that surfaced, but now with less fear attached to it). Over time, this can significantly diminish the power of those triggers. There is evidence from brain imaging that even long after the drug, the emotional processing circuits remain adaptively altered – for instance, months later, people who’ve had a series of ayahuasca sessions show changes in brain structure (ACC thickness) and function that correspond to more mindful, less reactive emotional styles (A systematic review of human studies assessing psychiatric ...) ((PDF) Psychedelics and the new behaviourism: considering the integration of third-wave behaviour therapies with psychedelic-assisted therapy). In practical terms, one might notice greater resilience as an increased gap between stimulus and response: after integration, something that once provoked anxiety or anger may now be met with a reflective pause, drawing on the insight that “I have felt this before and moved through it.” Additionally, many report that the experience of ego-dissolution or spiritual insight on DMT gives them a lasting sense of peace or trust in life, which buffers stress. To strengthen emotional resilience, it’s helpful to maintain supportive habits (adequate sleep, exercise, social connection) following the session, as these provide a stable foundation for the brain to reorganize in healthy ways. If negative emotions resurge in the weeks after, integration techniques like grounding exercises, breathing techniques, or simply revisiting the lessons of the DMT session (rereading one’s journal) can help one recall the context around those emotions and thereby handle them more skillfully. With time, the individual builds confidence that they are not controlled by their emotions and can navigate life’s challenges with a new-found adaptability – a core aspect of resilience.
- Maintaining Motivation and Positive Change: A common outcome of therapeutic DMT sessions is a revitalized sense of motivation – whether it’s motivation to break a bad habit, engage in creative work, or simply to live more fully. Psychedelics often ignite what patients describe as a “reset” or a reconnection with purpose. For example, people struggling with substance abuse or apathy may, during an insightful trip, rekindle memories of activities they loved or see the self-destructive behavior from a new, unacceptable angle, thus fueling motivation to change. Integration therapists harness this by helping the person set concrete intentions and “next steps” immediately after the session. Scientific literature on behavior change supports this approach: one review noted that psychedelics could be used to promote positive lifestyle changes by enhancing psychological flexibility and motivation (Psychedelics and health behaviour change - PMC - PubMed Central). In clinical trials for addiction, such as psilocybin for smoking cessation, very high success rates were achieved, partly attributed to participants’ profound shift in motivation to stay abstinent after the psychedelic experience. Likewise, in depression studies, patients often report a return of interest in hobbies and social interactions that they had lost desire for – essentially an anti-apathetic effect – following psychedelic therapy. To optimize and sustain these motivational benefits, a person should embed their new intentions into daily routines quickly. Tools like accountability partners or support groups can be valuable; for instance, someone who decides to exercise more can join a class or ask a friend to check in weekly. The integration phase can also involve creating visual reminders of one’s goals (inspired by the psychedelic insight) or scheduling periodic reflections to assess progress. Because DMT’s direct effects dissipate quickly, it’s this consistent follow-up that prevents one from sliding back into old ruts. The encouraging news from long-term observations is that many individuals do manage to maintain higher motivation and life satisfaction long after a psychedelic experience, especially if it was a part of a structured program. One study of ayahuasca users showed enduring increases in “Purpose in Life” and spiritual well-being scores a year later (Personality, psychopathology, life attitudes and neuropsychological performance among ritual users of Ayahuasca: a longitudinal study - PubMed), which underscores the lasting impact on one’s drive and sense of meaning. In summary, by pairing the initial surge of motivation from a DMT session with concrete plans, community support, and personal accountability, individuals can greatly improve the chances that their newfound drive results in sustained, positive life changes.
DMT vs. Other Psychedelics: Effectiveness and Considerations
How does DMT stack up against other psychedelics when it comes to fostering neuroplasticity, cognitive enhancement, and emotional regulation? Current evidence suggests that all classic serotonergic psychedelics share a core mechanism of promoting neuroplasticity and can produce broadly similar therapeutic outcomes – with some differences in experience profile and practical application. At the cellular level, DMT, psilocybin, LSD, and even compounds like MDMA or 5-MeO-DMT have each been shown to induce growth of neural connections. In head-to-head laboratory comparisons, DMT was as potent as LSD or psilocin in stimulating neurite outgrowth and synapse formation in cortical neurons (Psychedelics Promote Structural and Functional Neural Plasticity - PMC). In vivo, a high dose of DMT increased dendritic spine density in the rodent brain within 24 hours to a similar extent as ketamine, indicating robust plasticity-promoting effects (Psychedelics Promote Structural and Functional Neural Plasticity - PMC) (Psychedelics Promote Structural and Functional Neural Plasticity - PMC). This has led researchers to view these psychedelics as members of the same “psychoplastogen” class of drugs that can reopen the adult brain’s capacity for change (Psychedelics Promote Structural and Functional Neural Plasticity - PMC). Therefore, in terms of neurobiological potential, DMT is on par with psilocybin or LSD for catalyzing neural plasticity.Differences arise in duration and intensity of the subjective experience, which can influence how therapeutic integration is approached. DMT (in smoked or intravenous form) produces an extremely rapid and intense psychedelic state that lasts only ~15–30 minutes (hence it’s sometimes called a “blast-off” into an immersive hallucination). This brevity means that during the session there is limited opportunity for interactive psychotherapy – the person is often “far away” in their mind – so most therapeutic work with DMT happens in preparation and after the session. In contrast, psilocybin or LSD sessions last 4–8+ hours, during which a therapist can potentially guide the patient through various emotions or use techniques in real-time. Neither approach is inherently “better,” but they are different. Some experimental models are exploring extended DMT infusions to lengthen the experience for therapeutic purposes, but these are in early stages. Ayahuasca, the traditional DMT-containing brew, lasts longer (2–4 hours) due to the MAOIs co-administered, and in ceremonial or therapeutic contexts, facilitators often interact with participants (through music, counseling, etc.) during the experience, somewhat akin to how psilocybin sessions are conducted.
When it comes to therapeutic outcomes, much of the published research to date has focused on psilocybin and MDMA (for PTSD) in clinical trials, simply because these entered the research arena earlier. Those studies have shown remarkable efficacy for depression, end-of-life anxiety, PTSD, and addiction. DMT and ayahuasca studies, while fewer, show comparable promising outcomes. For example, small clinical trials of ayahuasca in treatment-resistant depression found rapid antidepressant effects within 1–2 days after a single session, superior to placebo, with improvements still significant a week later ([EPUB] The Impact of Ayahuasca on Suicidality: Results From a ... - Frontiers). Observational studies in naturalistic settings have reported reduced symptoms of depression and anxiety after ayahuasca ceremonies, and increased mindfulness and psychological well-being. In one report, ayahuasca users experienced sub-acute improvements in emotion regulation (e.g. less avoidance of emotions, more acceptance) and these improvements correlated with better cognitive performance and mood (Emotion regulation effects of Ayahuasca in experienced subjects ...) (Persisting Effects of Ayahuasca on Empathy, Creative Thinking ...). Another study noted that ayahuasca can help people engage cognitive reappraisal of negative experiences – essentially reframing thoughts – even acutely (Prospective examination of the therapeutic role of psychological ...). These are the same kinds of benefits attributed to psilocybin therapy. Similarly, 5-MeO-DMT (a short-acting psychedelic distinct from N,N-DMT) has shown in survey studies to produce longer-term increases in life satisfaction and mindfulness and decreases in stress up to 4 weeks after use (The potential of 5‐methoxy‐N,N‐dimethyltryptamine in the treatment ...) (though more controlled research is needed). The consensus in the field is that the classical psychedelics do not wildly differ in what psychological benefits they can produce – factors like set (mindset), setting, guidance, and the individual’s personal readiness likely play a bigger role in outcomes than the specific compound used. All these substances can, under the right conditions, facilitate mystical-type experiences, deep emotional breakthroughs, and cognitive flexibility that translate to therapeutic gains (Learning to Let Go: A Cognitive-Behavioral Model of How Psychedelic Therapy Promotes Acceptance - PMC). Indeed, a broad review of psychedelic therapy cases found that psilocybin, LSD, and ayahuasca all can lead to “sustained symptom reductions” in various disorders when paired with therapy (Learning to Let Go: A Cognitive-Behavioral Model of How Psychedelic Therapy Promotes Acceptance - PMC).
However, some practical distinctions are worth noting: DMT’s intensity can be challenging for some individuals – the onset is so fast that it can be jarring, and the content can be extremely bizarre or ego-dissolving. This can be overwhelming, though the short duration means even a difficult trip is over soon. Psilocybin’s gentler onset and longer plateau might allow a more gradual confrontation of issues. From a cognitive enhancement perspective, the short duration of DMT could be seen as a benefit (a powerful session could be done in an hour, vs. a whole day for an LSD session), but it also means there is less time during the experience to consciously work on a problem or engage in a task. Thus, for goals like improving creativity or problem-solving, some researchers have looked more at LSD or psilocybin in moderate doses where participants can still communicate and work on puzzles. DMT’s contribution here might be more about giving a lightning bolt of insight which is then unpacked afterward. On the other hand, ayahuasca’s rich tradition of integration in community (sharing circles, ritual practice) is a strength that often accompanies DMT use in that form, potentially yielding very strong support systems for change – something individual psilocybin sessions might lack unless done in group therapy settings.
In terms of safety and side-effect profile, DMT and other classical psychedelics are all non-addictive and physiologically well-tolerated (they do not cause organ damage and have low toxicity) (Psychedelics and Neuroplasticity: A Systematic Review Unraveling the Biological Underpinnings of Psychedelics - PMC). The risks are mainly psychological (e.g. precipitating anxiety or, rarely, psychosis in vulnerable individuals) and these apply to all in the class. No clear evidence suggests, for instance, that DMT is more likely to cause adverse reactions than psilocybin; if anything, the extensive ceremonial use of ayahuasca over centuries provides a case for its relative safety when used responsibly.
Overall, if one’s goal is cognitive enhancement, motivation, and emotional resilience, the choice of psychedelic may be less important than the surrounding framework. DMT is a valid option that can produce profound insights and neuroplastic changes, but similar benefits might be achieved with psilocybin or LSD given proper guidance. The difference may lie in personal preference (some may prefer the brevity of DMT or the spiritual context of ayahuasca, whereas others might favor the depth of a longer psilocybin journey) and logistical considerations. Importantly, the scientific evidence base is strongest for psilocybin (due to more trials), but encouraging studies and anecdotal reports suggest that DMT/ayahuasca is equally effective in catalyzing positive change when delivered in a supportive therapeutic model. In practice, therapists and researchers are increasingly interested in combining these substances with modern therapeutic techniques – whether it’s DMT with CBT-based integration, or LSD with psychodynamic therapy – to see if certain pairings yield optimal results. As of now, no head-to-head trials definitively prove one psychedelic as superior to another for cognitive or emotional outcomes; ongoing studies are more focused on whether psychedelic-assisted therapy as a whole works, and it consistently does show beneficial effects across different substances.
Conclusion and Practical Implications
Experimental therapeutic models involving DMT show great promise in leveraging the brain’s neuroplastic potential to achieve cognitive enhancements, improved motivation, and better emotional regulation. The key insights from current research and practice are: (1) DMT catalyzes a surge in neural plasticity and psychological flexibility, creating a window of opportunity for change; (2) active integration practices – from therapy sessions to personal mindfulness routines – are crucial to reinforce and extend the positive changes post-session; (3) short-term gains can be solidified into medium- and long-term improvements in cognition and mental health if supported by continued practice and sometimes repeated sessions; and (4) DMT’s effects and uses align closely with those of other psychedelics like psilocybin, meaning lessons learned in psilocybin research are largely applicable to DMT as well. Practically, this means that individuals seeking to use DMT in a growth-oriented way should approach it not as a standalone “quick fix,” but as a catalyst embedded in a broader therapeutic process. Before the session, clear intentions and proper set/setting are essential; during the session, a safe environment and perhaps a guide will allow the experience to unfold constructively; and after the session, one should engage in systematic integration work – whether with a professional or through self-guided practices – to translate insights into action.For clinicians and researchers, the findings underscore the importance of developing structured integration protocols and possibly combining DMT sessions with established therapies (CBT, ACT, etc.) to maximize outcomes. The notion of psychedelics reopening a “critical period” of neuroplasticity (Critical Period Plasticity as a Framework for Psychedelic-Assisted ...) suggests that we have a limited but significant timeframe to introduce therapeutic learning when it will stick best. By treating the days after DMT as a form of accelerated learning bootcamp – focusing the patient on new thought patterns, exposing them to positive experiences, and encouraging adaptive behaviors – we can harness the neuroplastic boost for durable benefit. This represents a shift from seeing medication and therapy as separate: in psychedelic therapy, the medicine makes the brain receptive, and therapy provides the new input to be encoded.
It’s also worth noting the experimental nature of this field. While early results are exciting, more research is needed to fully understand optimal protocols (e.g. the ideal number of DMT sessions, how to personalize integration strategies, managing any risks). Comparisons between different psychedelics will help determine if one might be better suited for certain goals – for instance, perhaps DMT (ayahuasca) could be especially useful in spiritual or creative growth contexts, whereas psilocybin might be slightly more grounded for step-by-step cognitive training, but this remains to be empirically tested.
In practical application, those using DMT in ceremonial or non-clinical settings can still apply these principles: have integration activities lined up. For example, if you attend an ayahuasca retreat, plan for what you will do in the weeks afterward – therapy, journaling, making lifestyle changes – to nurture the seeds planted in the ceremony. Communities of experienced users often stress that “the real work begins after the ceremony.” The scientific concept of neuroplasticity gives credence to that, explaining why continued work is needed to remodel the brain in lasting ways.
In summary, DMT can be a powerful tool for cognitive and emotional growth when used responsibly and followed by intentional integration practices. It effectively “loosens the clay” of the mind, but it’s the subsequent shaping and molding – through conscious effort and support – that determines the ultimate outcomes. With a structured approach that reinforces neuroplastic changes post-session, individuals can reasonably expect improvements in their thinking (more creativity, mental flexibility), their drive (renewed motivation and sense of purpose), and their emotional well-being (better regulation, resilience). As research progresses, we anticipate more refined therapeutic models and evidence-based techniques to optimize these outcomes. For now, the convergence of traditional wisdom (from indigenous use of DMT in ayahuasca) and modern neuroscience is teaching us how to integrate the profound experiences DMT offers into enduring positive change, marking an exciting frontier in mental health and human cognitive enhancement ((PDF) Psychedelics and the new behaviourism: considering the integration of third-wave behaviour therapies with psychedelic-assisted therapy) ((PDF) Psychedelics and the new behaviourism: considering the integration of third-wave behaviour therapies with psychedelic-assisted therapy).
Sources:
- Ly et al., Cell Reports (2018) – Psychedelics promote structural and functional neural plasticity (Psychedelics Promote Structural and Functional Neural Plasticity - PMC).
- Hutten et al., Front. Pharmacol. (2019) – Effects of microdosing psychedelics on creativity and reasoning (Frontiers | Psychedelic Cognition—The Unreached Frontier of Psychedelic Science).
- Wolff et al., Front. Psychiatry (2020) – Learning to Let Go: A cognitive-behavioral model of psychedelic therapy (Learning to Let Go: A Cognitive-Behavioral Model of How Psychedelic Therapy Promotes Acceptance - PMC) (Learning to Let Go: A Cognitive-Behavioral Model of How Psychedelic Therapy Promotes Acceptance - PMC).
- Uthaug et al., Front. Pharmacol. (2021) – Persisting effects of ayahuasca on empathy, creative thinking, and well-being up to 7 days post-session (Frontiers | Persisting Effects of Ayahuasca on Empathy, Creative Thinking, Decentering, Personality, and Well-Being).
- Bouso et al., PLOS ONE (2012) – Long-term ayahuasca use associated with improved executive function, lower psychopathology, and greater well-being (Personality, psychopathology, life attitudes and neuropsychological performance among ritual users of Ayahuasca: a longitudinal study - PubMed) (Personality, psychopathology, life attitudes and neuropsychological performance among ritual users of Ayahuasca: a longitudinal study - PubMed).
- Doss et al., Transl. Psychiatry (2021) – Psilocybin therapy trial showing increased cognitive flexibility 4 weeks after treatment (Psilocybin therapy increases cognitive and neural flexibility in patients with major depressive disorder - PubMed).
- Arruda-Sanchez et al., J. Ethnopharmacol. (2024) – fMRI study: Ayahuasca acutely enhances emotion regulation (reduced amygdala response) (Emotion regulation effects of Ayahuasca in experienced subjects during implicit aversive stimulation: An fMRI study - PubMed) (Emotion regulation effects of Ayahuasca in experienced subjects during implicit aversive stimulation: An fMRI study - PubMed).
- Thiessen et al., J. Psychopharmacol. (2018) – Psychedelic use linked to improved emotion regulation and relationship outcomes ((PDF) Psychedelics and the new behaviourism: considering the integration of third-wave behaviour therapies with psychedelic-assisted therapy).
- Sarris et al., Psychopharmacology (2021) – Review of ayahuasca: noted increased cortical thickness in ACC in long-term users (A systematic review of human studies assessing psychiatric ...).
- Griffiths et al., J. Psychopharmacol. (2018) – Psilocybin study with spiritual practice support; meditation + psychedelic led to greater improvements ((PDF) Psychedelics and the new behaviourism: considering the integration of third-wave behaviour therapies with psychedelic-assisted therapy) ((PDF) Psychedelics and the new behaviourism: considering the integration of third-wave behaviour therapies with psychedelic-assisted therapy).
- McCulloch et al., Front. Neurosci. (2022) – Critical period plasticity as a framework for psychedelic therapy (Frontiers | Critical Period Plasticity as a Framework for Psychedelic-Assisted Psychotherapy) (Frontiers | Critical Period Plasticity as a Framework for Psychedelic-Assisted Psychotherapy).
- Davis et al., Front. Psych. (2019) – 5-MeO-DMT survey: increased life satisfaction and mindfulness after use (supports generalizability of psychedelic benefits) (The potential of 5‐methoxy‐N,N‐dimethyltryptamine in the treatment ...) (A Cognitive-Behavioral Model of How Psychedelic Therapy ...). (And additional sources within text.)
, now read all these papers and find your own truth.
